541 related articles for article (PubMed ID: 19394383)
1. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
Mashiko S; Moriya R; Ishihara A; Gomori A; Matsushita H; Egashira S; Iwaasa H; Takahashi T; Haga Y; Fukami T; Kanatani A
Eur J Pharmacol; 2009 Aug; 615(1-3):113-7. PubMed ID: 19482021
[TBL] [Abstract][Full Text] [Related]
5. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
6. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
7. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
[TBL] [Abstract][Full Text] [Related]
8. NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
Moriya R; Shirakura T; Hirose H; Kanno T; Suzuki J; Kanatani A
Peptides; 2010 Apr; 31(4):671-5. PubMed ID: 19925840
[TBL] [Abstract][Full Text] [Related]
9. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
[TBL] [Abstract][Full Text] [Related]
10. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
11. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
12. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
[TBL] [Abstract][Full Text] [Related]
13. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
[TBL] [Abstract][Full Text] [Related]
14. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
[TBL] [Abstract][Full Text] [Related]
15. PYY3-36 as an anti-obesity drug target.
Boggiano MM; Chandler PC; Oswald KD; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Schindler M; Arndt K; Rudolf K; Mark M; Schoelch C; Joost HG; Klaus S; Thöne-Reineke C; Benoit SC; Seeley RJ; Beck-Sickinger AG; Koglin N; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Ortmann S; Castañeda TR; Tschöp M
Obes Rev; 2005 Nov; 6(4):307-22. PubMed ID: 16246216
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.
Rahardjo GL; Huang XF; Tan YY; Deng C
Endocrinology; 2007 Oct; 148(10):4704-10. PubMed ID: 17615145
[TBL] [Abstract][Full Text] [Related]
17. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
19. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.
Ishihara A; Kanatani A; Mashiko S; Tanaka T; Hidaka M; Gomori A; Iwaasa H; Murai N; Egashira S; Murai T; Mitobe Y; Matsushita H; Okamoto O; Sato N; Jitsuoka M; Fukuroda T; Ohe T; Guan X; MacNeil DJ; Van der Ploeg LH; Nishikibe M; Ishii Y; Ihara M; Fukami T
Proc Natl Acad Sci U S A; 2006 May; 103(18):7154-8. PubMed ID: 16636293
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
